SOUTH KOREAN POLICE SEEK ARREST WARRANT FOR HYBE CHAIRMAN BANG SI-HYUK OVER ALLEGED $100 MILLION INVESTOR FRAUD SCHEME. (PHOTO).

Image
 South Korean police seek arrest warrant for Hybe chairman Bang Si-Hyuk over alleged $100 million investor fraud scheme    South Korean police are seeking an arrest warrant for Bang Si-Hyuk, the billionaire music executive behind K-pop powerhouse Hybe and BTS, as part of an expanding investigation into allegations that he improperly benefited from an investor scheme involving more than $100 million. Authorities said they have asked prosecutors to pursue a court warrant for Bang’s arrest as they continue probing claims that he misled investors in 2019. Investigators allege he told investors that Hybe had no plans for an initial public offering, leading them to sell shares to a private equity fund. The company later went public, and police suspect a separate arrangement may have resulted in Bang receiving a substantial payout tied to post-IPO stock profits. Bang’s legal team has not directly addressed the specific allegations but said he has cooperated with investigators an...

NIGERIA’S NAFDAC NOW A MEMBER OF ICH. (PHOTO). #PRESS RELEASE


 Nigeria’s NAFDAC now a member of ICH


The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) has confirmed Nigeria as a member.

Nigeria’s NAFDAC was admitted when the ICH Assembly met in Singapore from 18 to 19 November 2025, during its second in-person meeting this year. 


At the same assembly, South Africa’s SAHPRA was also admitted as a member, while DIGEMAPS, the Dominican Republic, and the Philippine FDA were admitted as Observers.


The 35-year-old ICH now has 25 Members and 41 Observers. 


ICH Membership criteria for national regulatory authorities include implementation of at least the three Tier 1 ICH Guidelines (Q1 Stability Testing Guidelines, Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients, and E6 Good Clinical Practice Guideline), participation in ICH biannual meetings, and a plan for implementing all ICH Guidelines. 


ICH brings together regulatory authorities and the pharmaceutical industry to discuss the scientific and technical aspects of pharmaceutical development. 


The association produces harmonised technical requirements to ensure the development and registration of safe, effective and high-quality medicines for human use.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.